Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Carcinoma, Non-Small-Cell Lung 184Neoplasm Metastasis 149Neoplasms 140Leukemia, Myeloid, Acute 133Colorectal Neoplasms 131Breast Neoplasms 122Melanoma 94Ovarian Neoplasms 93Recurrence 88Prostatic Neoplasms 88Multiple Myeloma 84Pancreatic Neoplasms 76Squamous Cell Carcinoma of Head and Neck 74Lung Neoplasms 74Glioblastoma 74Lymphoma, Non-Hodgkin 67Myelodysplastic Syndromes 62Triple Negative Breast Neoplasms 58Glioma 56Precursor Cell Lymphoblastic Leukemia-Lymphoma 53Stomach Neoplasms 52Endometrial Neoplasms 50Brain Neoplasms 48Carcinoma, Renal Cell 47Small Cell Lung Carcinoma 46Lymphoma, Large B-Cell, Diffuse 46Carcinoma, Hepatocellular 45Lymphoma, Follicular 41Lymphoma, B-Cell 41Sarcoma 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Advanced Solid Tumor Malignancies × 90 days × Clear all
NCT06927297 2026-03-17

Phase I Study of the Safety, Tolerability, and Efficacy of an Engineered Mitochondrial Vaccine in Advanced Solid Tumors

West China Hospital

Phase 1 Recruiting
12 enrolled
Other solid neoplasm

Advanced Solid Tumor Malignancies

NCT07475559 2026-03-16

JSKN016HC in Patients With Advanced or Metastatic Solid Malignant Tumors

Jiangsu Alphamab Biopharmaceuticals Co., Ltd

Phase 1 Not yet recruiting
42 enrolled
Other solid neoplasm

Advanced Solid Tumor Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡